| Michael J Murphy, MD | |
|
263 Farmington Ave, Farmington, CT 06030-0001 | |
| (860) 679-4600 | |
| (860) 679-1248 |
| Full Name | Michael J Murphy |
|---|---|
| Gender | Male |
| Speciality | Dermatology - Dermatopathology |
| Location | 263 Farmington Ave, Farmington, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780681122 | NPI | - | NPPES |
| 1387845 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 038784 (Connecticut) | Secondary |
| 207ND0900X | Dermatology - Dermatopathology | 038784 (Connecticut) | Primary |
| Entity Name | University Of Connecticut Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720083769 PECOS PAC ID: 3678472016 Enrollment ID: O20040106000105 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study. The FREEDOM data will be presented in posters at the American Society of Nephrology (ASN) Renal Week 2009, from October 27th to November 1st in San Diego.
Where you live affects the type of bacteria that cause bloodstream infections, according to researchers at Rhode Island Hospital and an international team of investigators. The closer you live to the equator, the greater the likelihood of a bloodstream infection caused by a group of bacteria called Gram-negative bacteria, which thrive in warm and moist environments, compared to another group of bacteria referred to as Gram-positive bacteria.
McClatchy/The Miami Herald reports on Ian Pearl, a South Florida man born with muscular dystrophy who is drawing attention to discriminatory health insurance practices against the disabled. Pearl is the "inspiration for 'Ian's Law,' legislation being introduced by two New York state legislators that would require insurance companies to get approval from the state before dropping coverage plans for existing clients."
The U.S. Food and Drug Administration today approved Yervoy to treat patients with late-stage melanoma, the most dangerous type of skin cancer.
Hard to Treat Diseases, Inc. is pleased to announce the second poster presentation researchers from its Slavica BioChem division have presented at the 8th World Congress on the Brain Injury, held in Washington, DC, March 10-14, 2010, under the auspices of The International Brain Injury Association.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Murphy, MD 263 Farmington Avenue, Provider Enrollment, West Hartford, CT 06119-2212 Ph: (860) 679-7503 | Michael J Murphy, MD 263 Farmington Ave, Farmington, CT 06030-0001 Ph: (860) 679-4600 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study. The FREEDOM data will be presented in posters at the American Society of Nephrology (ASN) Renal Week 2009, from October 27th to November 1st in San Diego.
Where you live affects the type of bacteria that cause bloodstream infections, according to researchers at Rhode Island Hospital and an international team of investigators. The closer you live to the equator, the greater the likelihood of a bloodstream infection caused by a group of bacteria called Gram-negative bacteria, which thrive in warm and moist environments, compared to another group of bacteria referred to as Gram-positive bacteria.
McClatchy/The Miami Herald reports on Ian Pearl, a South Florida man born with muscular dystrophy who is drawing attention to discriminatory health insurance practices against the disabled. Pearl is the "inspiration for 'Ian's Law,' legislation being introduced by two New York state legislators that would require insurance companies to get approval from the state before dropping coverage plans for existing clients."
The U.S. Food and Drug Administration today approved Yervoy to treat patients with late-stage melanoma, the most dangerous type of skin cancer.
Hard to Treat Diseases, Inc. is pleased to announce the second poster presentation researchers from its Slavica BioChem division have presented at the 8th World Congress on the Brain Injury, held in Washington, DC, March 10-14, 2010, under the auspices of The International Brain Injury Association.
› Verified 7 days ago
Philip E Kerr, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 21 South Rd, Dermatology, Farmington, CT 06032 Phone: 860-679-4600 Fax: 860-679-1248 | |
Fludiona Naka, MD, MPH Dermatology Medicare: Medicare Enrolled Practice Location: 399 Farmington Ave Ste 260, Farmington, CT 06032 Phone: 860-676-7000 | |
Adrienne B Berke, MD Dermatology Medicare: Medicare Enrolled Practice Location: 21 South Rd, Dermatoloty, Farmington, CT 06032 Phone: 860-679-4600 Fax: 860-679-1248 | |
Diane L Whitaker, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4600 Fax: 860-679-1248 | |
Dr. Arni Kjalar Kristjansson, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 21 South Rd, Farmington, CT 06032 Phone: 860-679-3474 Fax: 860-679-1267 | |
Jenna Bordelon Kelsey, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 21 South Rd, Farmington, CT 06032 Phone: 860-679-4600 Fax: 860-679-3207 | |
Diane Hoss, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4600 |